| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |